2. Why are we here?
• Find out about current REG activities:
o Research
o Quality standards
• Generate ideas for new REG activities:
o Addressing the “guidelines issue”
• Hear about other real-life work REG
collaborators are involved in
• Generate ideas for new REG related activities
3. Why are we here?
• Find out about current REG activities:
o Research
o Quality standards
• Generate ideas for new REG activities:
o Addressing the “guidelines issue”
• Hear about other real-life work REG
collaborators are involved in
• Generate ideas for new REG related activities
Please
speak out
Ideas sheets
to capture your
ideas &
suggestions
4. Meeting agenda (I)
• Welcome: David Price
• Brief updates: Alison Chisholm
• REG Research – developments and highlights:
o Asthma risk predictors – Mike Thomas
o Asthma adherence – Gene Colice
o COPDGene collaboration – Richard Martin
o Refractory Asthma and oral steroid burden – Liam Heaney
o COPD and blood eosinophils – David Price
o Nicotine replacement therapy and CV risk – David Price
o Early results from the asthma endpoint validation
study – Annie Burden
5. Meeting agenda (II)
• Quality standards work
o Highlights from Nicolas Roche followed by Group discussion
• Working with guideline bodies
o Thoughts from Eric Bateman followed by Group discussion
• Open Ideas Session / Sharing real-life project
information
o 3CIA initiative – CONCEPT (Joan Soriano)
o ASTROLAB (Eric van Ganse)
o Setting up a Complex Interventions Working
Group (Eric Bateman)
6. Australia: 3
Canada: 4
China: 2
Hong Kong: 1
Singapore: 1
Japan: 1
South Korea: 1
Denmark: 1
Germany: 3
Greece: 1
Bulgaria: 1
Italy: 2
Belgium: 1
France: 3
Netherlands: 6
Spain: 4
Sweden: 3
UK: 19
Ireland: 1
USA: 22
South Africa: 1
Brazil: 1
82 leading respiratory experts
united across 23 different countries
Venezuela: 1
So, to give you a sense of the REG collaborators as they exist today, we now have 80 expert collaborators working across 22 different countries
I want to emphasise that among the REG group are many of the leading respiratory physicians, methodologists and researchers in the world – the list of names speaks for itself.
The names in bold are the members of the management steering committee – selected to represent different the group as a whole – guideline and methodology experts, COPD experts, asthma experts, primary and secondary care experts, health economists, etc.
So, to give you a sense of the REG collaborators as they exist today, we now have 80 expert collaborators working across 22 different countries
I want to emphasise that among the REG group are many of the leading respiratory physicians, methodologists and researchers in the world – the list of names speaks for itself.
The names in bold are the members of the management steering committee – selected to represent different the group as a whole – guideline and methodology experts, COPD experts, asthma experts, primary and secondary care experts, health economists, etc.